1 / 10

Belov Artem , CFO

Belov Artem , CFO. 123458, Moscow, Str. Twardowski, 8 / 1, office 405 Skype: artem.belov.msp phone : +7 ( 925 ) 859-10-85 artem.belov@microspace.pro. The product. Known approach of cancer tissue diagnostic. 1. Number of tumor cells. 2. Intensity of staining.

livvy
Download Presentation

Belov Artem , CFO

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BelovArtem, CFO 123458, Moscow, Str. Twardowski, 8/1, office 405 Skype: artem.belov.msp phone : +7 (925) 859-10-85 artem.belov@microspace.pro

  2. The product Known approach of cancer tissue diagnostic 1. Number of tumor cells 2. Intensity of staining Our approach based on both known measurements + Identify the number of antigens in each cell directly (Efficiency is proved by Russian state pathologist burro)

  3. Uniqueness Score evaluation Antigens distribution Microspace shows real distribution of antigens in tumor cells +2 Analogues (Leica, Carl Zeiss) shows one rough parameter of antigens in tumor cells Precise knowledge on antigens allows development of muchmore efficient treatment plans

  4. Microspace equipment use for developing the new approach Market leadership through better efficiency of cancer therapy

  5. Microspace Team • Experience in international projects • 30 years of medical experience • 20 years experience in development

  6. Global market Market size: - 190 ml. USD in 2012. - 150 thousands diagnostic systems. Tripling of the market by 2020! CAGR till 2018 – 23%.

  7. Business model Hardware – B2Bsegment for major Distributor Software – B2C, B2B segment • Advantages: • Great market potential of new approach • Unique technology and protectable IP

  8. Main budget figures • 2014 - $ 0.7 ml to launch the products in Russia and patenting processes • Reaching breakeven point in the 2nd qr. 2015 • 2015 -2017 – Exit or next round for scaling

  9. Great opportunity of industrial take over within 2-4 years By this time, Microspace will be: - Leader of digital pathology in Russia - Pioneer of new technology wave in the global scale More than 10 comparable takeovers

  10. Artem Belov, CFO Thank you for attention 123458, Moscow, Str. Twardowski, 8/1, office 405 Skype: artem.belov.msp phone: +7 (925) 859-10-85 artem.belov@microspace.pro

More Related